Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study

We reviewed the medical records of 43 patients with a median age of 49 years treated with double-scattered 3D conformal proton therapy for skull-base chondrosarcomas between January 2007 and February 2016

Adam L. Holtzman

2019

Scholarcy highlights

  • We sought to evaluate the effectiveness of definitive or adjuvant external-beam proton therapy on local control and survival in patients with skull-base chondrosarcoma
  • We reviewed the medical records of 43 patients with a median age of 49 years treated with double-scattered 3D conformal proton therapy for skull-base chondrosarcomas between and
  • Further follow-up of this cohort is necessary to better characterize long-term disease control and late toxicities

Need more features? Save interactive summary cards to your Scholarcy Library.